menu
close
Toll-Free 1-866-625-9854

Rifocyna (Rifamycin)

Active Ingredient: Rifamycin
Dosage: 1 g/10 ml
Route of Administration: Local
Dosage Form: Solution
Quantity per package: 50 tablets per pack
Availability: Out of stock

Why is Rifocyna not used in the USA?

Rifocyna is not used in the USA possibly due to the availability of alternative medications that are already widely accepted and integrated into the healthcare system. Regulatory differences might also play a role, as the drug might not have approval from the U.S. Food and Drug Administration (FDA) for use in the States.

Similar Drugs Available in the USA for Treating Skin Conditions and Infections

Dermatitis

Skin Infections and Infected Wounds

Skin Ulcers

See also  Amoxibron (Amoxicillin, Bromhexine)

Abscesses

Sores and Fistulas

Pyodermatitis

What is Rifocyna?

Rifocyna spray is used to treat and prevent infections caused by susceptible microorganisms: pyodermatitis and dermatitis; sores, skin ulcers, abscesses, infected wounds, open wounds and tracts, fistulas. The drug contains Rifamycin as an active ingredient. The active ingredient, Rifamycin, is effective against a broad spectrum of bacteria, making it suitable for treating infections in open wounds and similar conditions.

Indications

Treatment and prophylaxis of infections caused by susceptible microorganisms:

pyodermatitis and dermatitis;

sores, skin ulcers, abscesses, infected wounds, open wounds and tracts, fistulas.

Dosage and administration

Rifocyna is suitable for washing the cavity after aspiration of the purulent content. It is also recommended for external local application (wounds, sores or boils) or for the preparation of compresses.

The medicine should be changed once a day or every third day.

See also  Generic Zithromax Online – Uninsured Americans Get Affordable Antibiotic Therapies

The topical application of Rifocyna can be combined with the administration of systemic antibiotics.

In what countries Rifocyna is popular?

Rifocyna is particularly popular in some South American countries like Brazil and Mexico, and in parts of Southeast Asia including the Philippines and Indonesia. These regions may favor Rifocyna due to its effectiveness in treating common tropical infections that are prevalent in humid and warm climates. Economic factors such as cost-effectiveness compared to other antibiotics might also contribute to its popularity in these regions.

Contraindications

Hypersensitivity to rifamycins or the drug components.

Side effects

Reports of allergic or painful reactions at the application site are rarely recorded. In exceptional cases, there have been reports of severe systemic hypersensitivity reactions including shock or anaphylactic reactions, after topical application in continuous skin lesions or in other body areas.

Rifocyna can produce a reddish coloration of body tissues and/or fluids such as skin, teeth, tongue, urine, feces, saliva, sputum, tears, sweat and cerebrospinal fluid. Contact lenses, teeth or dentures can become permanently dyed.

Overdose

No cases of overdose have been reported due to the topical use of rifamycin solution.

Interaction

With topical therapy, interaction with cyclosporine is possible.